CLINICAL_TRIALS
research
· 2025-05-14
Clinical Trial Update: Blood and Urine HPVDNA as Minimally Invasive Biomarkers for Cervical Cancer Detection and Surveillance Following Treatment
Summary
This entry reports a clinical trial evaluating blood and urine HPV DNA as minimally invasive biomarkers for detecting cervical cancer and for post-treatment sur…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Cervical Cancer | Status: RECRUITING